Stephan Huijbregts

Dr. Stephan Huijbregts

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2017 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
AWAnnemiek van Wegberg
Annemiek van Wegberg
AMAnita MacDonald
Anita MacDonald
KAK. Ahring
K. Ahring
ABAmaya Belanger-Quintana
Amaya Belanger-Quintana
NBNenad Blau
Nenad Blau
FSFrancjan J. Van Spronsen
Francjan J. Van Spronsen
Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine metabolism caused by deficiency in the enzyme phenylalanine hydroxylase that converts phenylalanine into tyrosine. If left untreated, PKU results in increased phenylalanine concentrations in blood and brain, which cause severe intellectual disability, epilepsy and behavioural problems. PKU management differs widely across Europe and therefore these guidelines have been developed aiming to optimize and standardize PKU care. Professionals from 10 different European countries developed the guidelines according to the AGREE (Appraisal of Guidelines for Research and Evaluation) method. Literature search, critical appraisal and evidence grading were conducted according to the SIGN (Scottish Intercollegiate Guidelines Network) method. The Delphi-method was used when there was no or little evidence available. External consultants reviewed the guidelines. Using these methods 70 statements were formulated based on the highest quality evidence available. The level of evidence of most recommendations is C or D. Although study designs and patient numbers are sub-optimal, many statements are convincing, important and relevant. In addition, knowledge gaps are identified which require further research in order to direct better care for the future.

1 September 2017 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Closed access
FSFrancjan J. Van Spronsen
Francjan J. Van Spronsen
AWAnnemiek Mj van Wegberg
Annemiek Mj van Wegberg
KAKirsten Ahring
Kirsten Ahring
ABAmaya Bélanger-Quintana
Amaya Bélanger-Quintana
NBNenad Blau
Nenad Blau
AMAnita MacDonald
Anita MacDonald

1 November 2003 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
JSJoseph A Sergeant
Joseph A Sergeant
HGHilde Geurts
Hilde Geurts
SHStephan Huijbregts
Stephan Huijbregts
ASAnouk Scheres
Anouk Scheres
JOJaap Oosterlaan
Jaap Oosterlaan

27 July 2004 in Neurology
Verified
Journal Article
Closed access
PDF file
SHStephan Huijbregts
Stephan Huijbregts
NKN. F. Kalkers
N. F. Kalkers
LSL. M.J. de Sonneville
L. M.J. de Sonneville
VGV. de Groot
V. de Groot
IRI. E.W. Reuling
I. E.W. Reuling
CPC. H. Polman
C. H. Polman
Objective: To investigate the cognitive skills of patients with relapsing remitting multiple sclerosis (RRMS), secondary progressive MS (SPMS), and primary progressive MS (PPMS) relative to healthy control subjects and to assess whether there is heterogeneity in the type of cognitive disabilities demonstrated by patients with different MS phenotypes. Methods: RRMS patients (n = 108), SPMS patients (n = 71), PPMS patients (n = 55), and healthy control subjects (n = 67) underwent neuropsychological assessment with the Brief Repeatable Battery of Neuropsychological Tests. Results: Relative to controls, cognitive performance of RRMS patients was deficient when tasks required higher-order working memory (WM) processes (Word List Generation, 10/36 Spatial Recall Test, Symbol Digit Modalities Test). PPMS and SPMS patients performed poorer than control subjects on all tasks. SPMS patients performed more poorly than PPMS patients when tasks required higher-order WM processes, except when speed of information processing played a relatively important role (Symbol Digit Modalities Test, Paced Auditory Serial Addition Test). Whereas RRMS patients generally performed better than the progressive subtypes, they showed relatively poor verbal fluency. Conclusion: MS patients with different disease courses have different cognitive profiles.

1 January 2010 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
SCShawn E. Christ
Shawn E. Christ
SHStephan Huijbregts
Stephan Huijbregts
LSLeo M.J. de Sonneville
Leo M.J. de Sonneville
DWDesirée A. White
Desirée A. White

1 June 2006 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
SHStephan Huijbregts
Stephan Huijbregts
NKNynke F. Kalkers
Nynke F. Kalkers
LSLeo M.J. de Sonneville
Leo M.J. de Sonneville
VGVincent de Groot
Vincent de Groot
CPChris H. Polman
Chris H. Polman